Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

644 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The direct PAK1 inhibitor, TAT-PAK18, blocks preferentially the growth of human ovarian cancer cell lines in which PAK1 is abnormally activated by autophosphorylation at Thr 423.
Hashimoto H, Sudo T, Maruta H, Nishimura R. Hashimoto H, et al. Among authors: sudo t. Drug Discov Ther. 2010 Feb;4(1):1-4. Drug Discov Ther. 2010. PMID: 22491145
Ivermectin inactivates the kinase PAK1 and blocks the PAK1-dependent growth of human ovarian cancer and NF2 tumor cell lines.
Hashimoto H, Messerli SM, Sudo T, Maruta H. Hashimoto H, et al. Among authors: sudo t. Drug Discov Ther. 2009 Dec;3(6):243-6. Drug Discov Ther. 2009. PMID: 22495656
Correlative expression of cyclooxygenase-1 (Cox-1) and human epidermal growth factor receptor type-2 (Her-2) in endometrial cancer.
Sugimoto T, Koizumi T, Sudo T, Yamaguchi S, Kojima A, Kumagai S, Nishimura R. Sugimoto T, et al. Among authors: sudo t. Kobe J Med Sci. 2007;53(5):177-87. Kobe J Med Sci. 2007. PMID: 18204294
Pathogenesis of combined high-grade squamous intraepithelial lesion and adenocarcinoma in situ of the uterine cervix: human papillomavirus genotype and methylation status and immunohistochemical study.
Kawakami F, Semba S, Itami H, Oka N, Sudo T, Ebina Y, Ohbayashi C, Mikami Y, Yokozaki H, Itoh T. Kawakami F, et al. Among authors: sudo t. Kobe J Med Sci. 2014 Nov 6;60(3):E66-73. Kobe J Med Sci. 2014. PMID: 25612672
Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review.
Nagao S, Miwa M, Maeda N, Kogiku A, Yamamoto K, Morimoto A, Wakahashi S, Ichida K, Sudo T, Yamaguchi S, Sakuma T, Fujiwara K. Nagao S, et al. Among authors: sudo t. Int J Gynecol Cancer. 2015 Sep;25(7):1300-5. doi: 10.1097/IGC.0000000000000495. Int J Gynecol Cancer. 2015. PMID: 26166556 Clinical Trial.
Transformed Follicular Lymphoma (TFL) Predicts Outcome in Advanced Endometrial Cancer.
Wakahashi S, Kawakami F, Wakahashi K, Minagawa K, Matsuo K, Katayama Y, Yamada H, Matsui T, Sudo T. Wakahashi S, et al. Among authors: sudo t. Cancer Epidemiol Biomarkers Prev. 2018 Aug;27(8):963-969. doi: 10.1158/1055-9965.EPI-17-0762. Epub 2018 May 21. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29784731
Endometrial stromal sarcoma: clinicopathological and immunophenotypic study of 16 cases.
Iwasaki S, Sudo T, Miwa M, Ukita M, Morimoto A, Tamada M, Ueno S, Wakahashi S, Yamaguchi S, Fujiwara K, Sakuma Y, Mikami Y, Nishimura R. Iwasaki S, et al. Among authors: sudo t. Arch Gynecol Obstet. 2013 Aug;288(2):385-91. doi: 10.1007/s00404-013-2766-3. Epub 2013 Feb 23. Arch Gynecol Obstet. 2013. PMID: 23435725
VAV1 represses E-cadherin expression through the transactivation of Snail and Slug: a potential mechanism for aberrant epithelial to mesenchymal transition in human epithelial ovarian cancer.
Wakahashi S, Sudo T, Oka N, Ueno S, Yamaguchi S, Fujiwara K, Ohbayashi C, Nishimura R. Wakahashi S, et al. Among authors: sudo t. Transl Res. 2013 Sep;162(3):181-90. doi: 10.1016/j.trsl.2013.06.005. Epub 2013 Jul 12. Transl Res. 2013. PMID: 23856093
Absence of human papillomavirus infection and activation of PI3K-AKT pathway in cervical clear cell carcinoma.
Ueno S, Sudo T, Oka N, Wakahashi S, Yamaguchi S, Fujiwara K, Mikami Y, Nishimura R. Ueno S, et al. Among authors: sudo t. Int J Gynecol Cancer. 2013 Jul;23(6):1084-91. doi: 10.1097/IGC.0b013e3182981bdc. Int J Gynecol Cancer. 2013. PMID: 23792604
L1 gene methylation in high-risk human papillomaviruses for the prognosis of cervical intraepithelial neoplasia.
Oka N, Kajita M, Nishimura R, Ohbayashi C, Sudo T. Oka N, et al. Among authors: sudo t. Int J Gynecol Cancer. 2013 Feb;23(2):235-43. doi: 10.1097/IGC.0b013e31827da1f6. Int J Gynecol Cancer. 2013. PMID: 23314283
644 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback